The XGBoost model predicts hyperglycemia risk in psoriasis patients with high accuracy, achieving an AUC of 0.821 in the training set. A web-based calculator was developed to facilitate personalized ...

Nimbus Therapeutics enters research collaboration with Lilly to develop novel oral treatment for obesity and other metabolic diseases: Boston, Massachusetts Thursday, January 8, 2 ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a drug discovery company developing breakthrough medicines ...

Dr. Vishal Sharma [email protected] Not long ago, the word “Artificial Intelligence (AI)” would bring to mind images of sci-fi robots, self-aware machines, or futuristic cities powered ...

Microbiome diagnostics and AI are redefining early disease detection, emphasizing the gut's impact on health and the ...

Addressing the microbiome's translational gap involves understanding biological complexity and developing function-driven, patient-specific interventions.

Successful implementation requires modern healthcare infrastructure, including reliable electricity, high-speed internet ...

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining ...

True ROI for R&D won't come from the tool that generates 10,000 new ideas. It will come from the tool that confidently tells ...

Recent advances in artificial intelligence (AI) have positioned the field as a transformative technological domain, with applications across many areas. AI ...